Immediate Impact

1 by Nobel laureates 31 standout
Sub-graph 1 of 13

Citing Papers

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
European Neuroendocrine Tumour Society ( ENETS ) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
2023 Standout
2 intermediate papers

Works of Hamzeh Albaba being referenced

Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer
2016
Efficacy of Capecitabine and Temozolomide Combination in Well-Differentiated Neuroendocrine Tumors
2014

Author Peers

Author Last Decade Papers Cites
Hamzeh Albaba 113 66 11 38 10 151
Manuel Sánchez Cánovas 99 25 15 26 15 148
Bernadette Vertogen 107 78 17 13 13 175
Annick Chevalier-Place 53 45 14 26 7 142
Jennifer Arena 160 56 40 59 15 178
Alice Baggi 63 60 11 22 13 103
Anas Alshawa 121 54 10 25 11 219
María Elena Elez 112 57 24 17 10 162
Melody Mendenhall 108 30 9 32 13 189
David García-Illescas 65 52 17 19 13 142
Helen Pasternack 75 88 44 19 11 181

All Works

Loading papers...

Rankless by CCL
2026